Therapeutic decision is mostly conditioned by patient's characteristics, stage, histologic grade, tumor burden, and risk-predicting factors.
To describe the clinical characteristics, staging and presentation of patients with familial exudative vitreoretinopathy (FEVR) in our clinical practice over the last 25 years.
Breast cancer characteristics (stage, number of positive lymph nodes, treatment) were verified using medical record review.
Other variables considered were demographic data and cancer characteristics (stage, grade, histology).
Trends in demographic characteristics, stage at detection and initial treatment mix were evaluated descriptively.
This threshold depends on the electric nature of the tumor and their physiological characteristics (stage, volume and histogenic characteristics).
The prognosis of MM varies dramatically based on host characteristics, stage, disease biology and response to therapy.
Additional multivariable models were adjusted for the following clinical characteristics: stage, grade, radiation treatment, and chemotherapy/hormonal therapy.
Multivariable models were adjusted for the following clinical characteristics: stage, grade of tumour, radiation treatment and chemotherapy/hormonal therapy.
Host characteristics, stage and disease biology are known at baseline and can help with selection of therapy.
